- Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases
Scientists report an advance toward “structure-based drug design,” with the potential to delay or treat Alzheimer’s disease, Parkinson’s disease, type II diabetes, ALS (also known as Lou Gehrig’s disease) and many other degenerative diseases.
- Genetic biomarker detects Lewy body dementia
Scientists have discovered the first genetic biomarker to detect Lewy body dementia (LBD), a disease that can be confused with Alzheimer’s. This biomarker is found in 20% of cases and differentiates one of the sub-groups of the pathology.
- Certain blood pressure drugs slow dementia deterioration
A class of drug, called ACE inhibitors, which are used to lower blood pressure, slow the rate of cognitive decline typical of dementia, suggests new research.
